Gilead Sciences, Inc. vs Regents of the University of Minnesota

Notice of Refund

Petitioner's Request for Refund

Granting Petitioners Motions for Pro Hac Vice Admission of Nevin M. Gewertz, Adam K. Mortara, J. Scott McBride, and Robert S. Schwartz 37 C.F.R. sec 42.10

DECISION Denying Institution of Inter Partes Review

Petitioner's Authorized Table of Supplemental Authority

Patent Owner's Response to Petitioner's Notice of Ranking Petitions

Petitioner's Notice

Conduct of the Proceeding 37 C.F.R. ¿¿ 42.5

ORDER Granting Patent Owner's Motion to Substitute Lead Counsel

Patent Owner's Unopposed Motion to Substitute Lead Counsel

Patent Owner's Second Updated Mandatory Notices

Patent Owner's Updated Power of Attorney

Chu 2003

Perno et al. 1989

Loudon 1995 ("Loudon")

Marquez et al. 1990 ("Marquez II")

Declaration of Victor E. Marquez, Ph.D ("Marquez Dec.")

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents ("DHHS 2004")

Marquez 1993 ("Marquez III")

Meier et al. 1999

U.S. Patent No. 6,703,396

Bechtel-Boenning 1996

Secrist et al. 2008

Marquez et al.1987 ("Marquez I")

Patent Owner's Preliminary Response

Denying Patent Owner's Motion to Dismiss

Patent Owner's Notice of Denial of Petition for Cert in Regents of the University of Minnesota v. LSI Corp.

PANEL CHANGE ORDER Conduct of the Proceedings 37 C.F.R. ¿¿ 42.5

Patent Owner's Notice of Filing Transcript of August 20, 2019 Conference Call

Transcript of August 20, 2019 Conference Call

Decision - 37 C.F.R. 42.71(b)

Exhibit 3001

Exhibit 3002

Petitioner¿¿¿s Fourth Amended Mandatory Notices

Petitioner's Third Amended Mandatory Notices

Decision Denying Petitioner's Request for Rehearing

January 26, 2018 Email Chain Between Counsel for Petitioner and Counsel for Patent Owner

Petitioner's Request for Rehearing

Preliminary Amendment, U.S. Patent Application No. 14/229,292, (Mar. 31, 2014)

Order, Regents of the University of Minnesota v. Gilead Sciences, Inc., Civil Action No. 0:16-cv-02915-SRN-HB, D.I. 139 (D. Minn. Jun. 9, 2017)

Stipulated Case Management Statement, Regents of the University of Minnesota v. Gilead Sciences, Inc., 17-cv-6056-VC, D.I. 275 (N.D. Cal. Jan. 2, 2018)

January 26, 2018 Email from Counsel for Patent Owner to Board and Counsel for Petitioner

January 28, 2018 Email from Counsel for Petitioner to Board and Counsel for Patent Owner

Stipulation and Proposed Order to Exclude Filings From IPR Proceedings, Regents of the Univ. of Calif. v. St. Jude Medical, LLC (N.D. Cal. Feb. 2, 2018)

Order, Regents of the University of Minnesota v. AT&T Mobility LLC (D. Minn. May 19, 2017)

Gilead's Motion to Stay Pending Inter Partes Review, Regents of the University of Minnesota v. Gilead Sciences, Inc., 17-cv-6056-VC, D.I. 297 (N.D. Cal. Feb. 7, 2018)

Transcript of October 24, 2017 Conference Call

Petitioner's Second Amended Exhibit List

Conduct of the Proceeding

Patent Owner Regents of the University of Minnesota's Reply in Support of its Motion to Dismiss

Gilead Sciences, Inc. Opposition to Regents of the University of Minnesota's Motion to Dismiss

Petitioner's Second Amended Mandatory Notices

Patent Owner's Updated Mandatory Notices

Patent Owner's Motion to Dismiss

University of Minnesota Charter

University of Minnesota's Consolidated Financial Statements (2015 & 2016)

Gilead Sciences, Inc.'s Answer to Plaintiff's Complaint for Patent Infringement

Patent Assignment

Conduct of the Proceeding

Petitioner's Motion For Admission Pro Hac Vice Of Nevin M. Gewertz Under 37 C.F.R. 42.10(c)

Petitioner's First Amended Exhibit List

Petitioner's First Amended Mandatory Notices

Declaration of Nevin M. Gewertz

Petitioner's Motion For Admission Pro Hac Vice Of Adam K. Mortara Under 37 C.F.R. 42.10(c)

Declaration of Adam K. Mortara

Petitioner's Motion For Admission Pro Hac Vice Of J. Scott McBride Under 37 C.F.R. 42.10(c)

Declaration of J. Scott McBride

Petitioner's Motion For Admission Pro Hac Vice Of Robert S. Schwartz Under 37 C.F.R. 42.10(c)

Declaration of Robert S. Schwartz

Notice of Accord Filing Date

Patent Owner's Mandatory Notices

Power of Attorney

Petition for Inter Partes Review of U.S. Patent No. 8,815,830

Petitioner's Power of Attorney

U.S. Patent No. 8,815,830

U.S. Patent No. 6,475,985

Certification and Request for Prioritized Examination Under 37 CFR 1.102(e), U.S. Patent Application Serial No. 14/229,292 (March 28, 2014)

TrackOne Grant, U.S. Patent Application Serial No. 14/229,292 (May 6, 2014)

Notice of Allowability, U.S. Patent Application Serial No. 14/229,292 (May 23, 2014)

U.S. Patent No. 6,348,587 (Schinazi)

Declaration of David MacMillan, Ph.D.

Curriculum Vitae of David MacMillan, Ph.D.

Complaint, Regents of the Univ. of Minn. v. Gilead Sciences, Inc., No. 0:16-cv-02915-SRN-HB (D. Minn., Aug. 29, 2016)

Rudolf Mengel & Wilhelm Guschlbauer, A Simple Synthesis of 2'-Deoxy-2'-fluorocytidine by Nucleophilic Substitution of 2,2'-Anhydrocytidine with Potassium Fluoride / Crown Ether, 17 (7) Angew. Chem, Int. Ed. Engl. 525 (1978)

Piet Herdewijn et al., Synthesis of Nucleosides Fluorinated in the Sugar Moiety. The Application of Diethylaminosulfur Trifluoride to the Synthesis of Fluorinated Nucleosides, 8(1) Nucleosides & Nucleotides 65 (1989)

Tokumi Maruyama et al., Synthesis and Anti-HIV Activity of 6-Substituted Purine 2'-Deoxy-2'Fluororibosides, Nucleosides & Nucleotides 13(1-3):527-37 (1994)

Yoshiko Sato et al., Synthesis and Hypnotic and Anti-Human Immunodeficiency Virus-1 Activities of N3-Substituted 2'-Deoxy-2'-fluorouridines, CHEM. PHARM. BULL. 42(3):595-98 (1994)